Market Value115,165,860
Total Holdings68
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TXG / 10x Genomics, Inc.
PRTA / Prothena Corporation plc
PTGX / Protagonist Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
BMY / Bristol-Myers Squibb Company
ALKS / Alkermes plc
FHTX / Foghorn Therapeutics Inc.
MASI / Masimo Corporation
HALO / Halozyme Therapeutics, Inc.
HROW / Harrow, Inc.
KALV / KalVista Pharmaceuticals, Inc.
MLTX / MoonLake Immunotherapeutics
PBAX / Phoenix Biotech Acquisition Corp.
OM / Outset Medical, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
QDEL / QuidelOrtho Corporation
KPTI / Karyopharm Therapeutics Inc.
CMPX / Compass Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
BDSX / Biodesix, Inc.
IFRX / InflaRx N.V.
LUNG / Pulmonx Corporation
CGEM / Cullinan Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
APGE / Apogee Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
UTHR / United Therapeutics Corporation
GOSS / Gossamer Bio, Inc.
FOLD / Amicus Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
KIDS / OrthoPediatrics Corp.
ELUT / Elutia Inc.
RARE / Ultragenyx Pharmaceutical Inc.
LQDA / Liquidia Corporation
NVCR / NovoCure Limited
SWTX / SpringWorks Therapeutics, Inc.
OVV / Ovintiv Inc.
KROS / Keros Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
SRRK / Scholar Rock Holding Corporation
AXSM / Axsome Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
NPCE / NeuroPace, Inc.
TSVT / 2seventy bio, Inc.
TECL / Direxion Shares ETF Trust - Direxion Daily Technology Bull 3X Shares
ATRA / Atara Biotherapeutics, Inc.
WVE / Wave Life Sciences Ltd.
ALMS / Alumis Inc.
CADL / Candel Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.
TMCI / Treace Medical Concepts, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
ZBIO / Zenas BioPharma, Inc.
TELA / TELA Bio, Inc.
CSTL / Castle Biosciences, Inc.
INBX / Inhibrx Biosciences, Inc.
AXGN / Axogen, Inc.
PHR / Phreesia, Inc.
DCGO / DocGo Inc.
ARVN / Arvinas, Inc.
SRPT / Sarepta Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
VTYX / Ventyx Biosciences, Inc.
BHVN / Biohaven Ltd.
CORT / Corcept Therapeutics Incorporated
NBIX / Neurocrine Biosciences, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
AXDX / Accelerate Diagnostics, Inc.
XNCR / Xencor, Inc.
EQT / EQT Corporation
QURE / uniQure N.V.